Add to ORKGThe introduction of tyrosine kinase inhibition Imatinib in the treatment of CML has revolutionized the history of the disease making obsolete all the previous therapies; however, in selected cases, old drugs retain their value
The publication provides an up-to-date review of the significance of cytogenetic abnormalities in ch...
Throughout its history, chronic myeloid leukemia (CML) has set precedents for cancer research and th...
Imatinib has become standard therapy for all phases of chronic myeloid leukemia (CML). However, data...
The introduction of tyrosine kinase inhibition Imatinib in the treatment of CML has revolutionized t...
Chronic myeloid leukaemia (CML) was the first neoplastic disease for which knowledge of the genotype...
The use of interferon-a (INF) in chronic myeloid leukemia, when it started in the 80s, was conside...
In early 2000, a better understanding of the molecular biology of chronic myeloid leukaemia establis...
Imatinib was the first signal transduction inhibitor (STI), used in a clinical setting. It prevents ...
International audienceImatinib has revolutionized the therapy of chronic myeloid leukaemia. However ...
Chronic myelogenous leukaemia (CML) is characterised by a t(9;22)(q34;q11) translocation, which prod...
Chronic myeloid leukemia (CML) is a poor prognostic disease which is characterized by Philadelphia c...
Chronic myelogenous leukaemia (CML) is characterised by a t(9;22)(q34;q11) translocation, which prod...
Chronic myeloid leukemia (CML) pioneered as the first human malignancy linked to a specific cytogene...
Management strategies of patients with chronic-phase chronic myeloid leukemia (CML) have been revolu...
Imatinib has revolutionized treatment strategies for chronic myeloid leukemia patients: long-term ov...
The publication provides an up-to-date review of the significance of cytogenetic abnormalities in ch...
Throughout its history, chronic myeloid leukemia (CML) has set precedents for cancer research and th...
Imatinib has become standard therapy for all phases of chronic myeloid leukemia (CML). However, data...
The introduction of tyrosine kinase inhibition Imatinib in the treatment of CML has revolutionized t...
Chronic myeloid leukaemia (CML) was the first neoplastic disease for which knowledge of the genotype...
The use of interferon-a (INF) in chronic myeloid leukemia, when it started in the 80s, was conside...
In early 2000, a better understanding of the molecular biology of chronic myeloid leukaemia establis...
Imatinib was the first signal transduction inhibitor (STI), used in a clinical setting. It prevents ...
International audienceImatinib has revolutionized the therapy of chronic myeloid leukaemia. However ...
Chronic myelogenous leukaemia (CML) is characterised by a t(9;22)(q34;q11) translocation, which prod...
Chronic myeloid leukemia (CML) is a poor prognostic disease which is characterized by Philadelphia c...
Chronic myelogenous leukaemia (CML) is characterised by a t(9;22)(q34;q11) translocation, which prod...
Chronic myeloid leukemia (CML) pioneered as the first human malignancy linked to a specific cytogene...
Management strategies of patients with chronic-phase chronic myeloid leukemia (CML) have been revolu...
Imatinib has revolutionized treatment strategies for chronic myeloid leukemia patients: long-term ov...
The publication provides an up-to-date review of the significance of cytogenetic abnormalities in ch...
Throughout its history, chronic myeloid leukemia (CML) has set precedents for cancer research and th...
Imatinib has become standard therapy for all phases of chronic myeloid leukemia (CML). However, data...